<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">0417625</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2839</journal-id>
<journal-id journal-id-type="nlm-ta">Cell Tissue Res</journal-id>
<journal-id journal-id-type="iso-abbrev">Cell Tissue Res.</journal-id>
<journal-title-group>
<journal-title>Cell and tissue research</journal-title>
</journal-title-group>
<issn pub-type="ppub">0302-766X</issn>
<issn pub-type="epub">1432-0878</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29589100</article-id>
<article-id pub-id-type="pmc">6893873</article-id>
<article-id pub-id-type="doi">10.1007/s00441-018-2820-3</article-id>
<article-id pub-id-type="manuscript">NIHMS955220</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic susceptibility to neuroblastoma: current knowledge and future directions</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Ritenour</surname>
<given-names>Laura E.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN2">+</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Randall</surname>
<given-names>Michael P.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN2">+</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bosse</surname>
<given-names>Kristopher R.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Diskin</surname>
<given-names>Sharon J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
<xref ref-type="author-notes" rid="FN1">*</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Cell and Molecular Biology Graduate Group, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA</aff>
<aff id="A2">
<label>2</label>Division of Oncology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA</aff>
<aff id="A3">
<label>3</label>Center for Childhood Cancer Research, Children’s Hospital of Philadelphia, Philadelphia, PA, USA</aff>
<aff id="A4">
<label>4</label>Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA</aff>
<aff id="A5">
<label>5</label>Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA</aff>
<author-notes>
<corresp id="FN1"><label>*</label>Corresponding Author: Sharon J. Diskin, Ph.D., Assistant Professor of Pediatrics, Division of Oncology Center for Childhood Cancer Research, Colket Translational Research Building 3026, 3501 Civic Center Boulevard, Philadelphia, PA 19104-4318, Phone: 215-590-9160, Fax: 267-426-0685, <email>diskin@email.chop.edu</email></corresp>
<fn fn-type="equal" id="FN2">
<label>+</label>
<p>Equal contribution</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>29</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>27</day>
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>5</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>05</day>
<month>12</month>
<year>2019</year>
</pub-date>
<volume>372</volume>
<issue>2</issue>
<fpage>287</fpage>
<lpage>307</lpage>
<!--elocation-id from pubmed: 10.1007/s00441-018-2820-3-->
<abstract>
<p id="P1">Neuroblastoma, a malignancy of the developing peripheral nervous system that affects infants and young children, is a complex genetic disease. Over the past two decades, significant progress has been made toward understanding the genetic determinants that predispose to this often lethal childhood cancer. Approximately 1-2% of neuroblastomas are inherited in an autosomal dominant fashion, and a combination of co-morbidity and linkage studies has led to the identification of germline mutations in <italic>PHOX2B</italic> and <italic>ALK</italic> as the major genetic contributors to this familial neuroblastoma subset. The genetic basis of “sporadic” neuroblastoma is being studied through a large genome-wide association study (GWAS). These efforts have led to the discovery of many common susceptibility alleles, each with modest effect size, associated with the development and progression of sporadic neuroblastoma. More recently, next-generation sequencing efforts have expanded the list of potential neuroblastoma-predisposing mutations to include rare germline variants with a predicted larger effect size. The evolving characterization of neuroblastoma’s genetic basis has led to a deeper understanding of the molecular events driving tumorigenesis, more precise risk stratification and prognostics, and novel therapeutic strategies. This review details the contemporary understanding of neuroblastoma’s genetic predisposition, including recent advances, and discusses ongoing efforts to address gaps in our knowledge regarding this malignancy’s complex genetic underpinnings.</p>
</abstract>
<kwd-group>
<kwd>neuroblastoma susceptibility</kwd>
<kwd>germline</kwd>
<kwd>familial neuroblastoma</kwd>
<kwd>genome-wide association studies</kwd>
<kwd>pediatric cancer</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>